nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Dinoprost Tromethamine—HPGDS—lung cancer	0.0108	0.741	CrCbGaD
Travoprost—PTGFR—respiratory system—lung cancer	0.00966	0.289	CbGeAlD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA5—lung cancer	0.0086	0.135	CbGpPWpGaD
Travoprost—PTGFR—bronchus—lung cancer	0.00795	0.238	CbGeAlD
Travoprost—PTGFR—trachea—lung cancer	0.00714	0.214	CbGeAlD
Travoprost—PTGFR—lung—lung cancer	0.00513	0.154	CbGeAlD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—lung cancer	0.00443	0.0694	CbGpPWpGaD
Travoprost—Tafluprost—PTGS2—lung cancer	0.00378	0.259	CrCbGaD
Travoprost—PTGFR—lymph node—lung cancer	0.00351	0.105	CbGeAlD
Travoprost—PTGFR—GPCRs, Other—GRM8—lung cancer	0.00301	0.0472	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—lung cancer	0.00173	0.0271	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GRP—lung cancer	0.00139	0.0218	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—OXTR—lung cancer	0.00139	0.0218	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GNG11—lung cancer	0.0013	0.0204	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—lung cancer	0.00125	0.0195	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—lung cancer	0.00125	0.0195	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNG11—lung cancer	0.00117	0.0183	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.00108	0.0169	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—ANXA1—lung cancer	0.00102	0.0161	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GIPR—lung cancer	0.001	0.0157	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—APP—lung cancer	0.000971	0.0152	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.000922	0.0145	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.000922	0.0145	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	0.000916	0.0144	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	0.000869	0.0136	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GRM8—lung cancer	0.000853	0.0134	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—AVP—lung cancer	0.000755	0.0118	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—OXTR—lung cancer	0.000702	0.011	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GRP—lung cancer	0.000702	0.011	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000679	0.0106	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000676	0.0106	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GNG11—lung cancer	0.000657	0.0103	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000643	0.0101	CbGpPWpGaD
Travoprost—Mental disorder—Docetaxel—lung cancer	0.000586	0.000659	CcSEcCtD
Travoprost—Arthralgia—Paclitaxel—lung cancer	0.000585	0.000658	CcSEcCtD
Travoprost—Myalgia—Paclitaxel—lung cancer	0.000585	0.000658	CcSEcCtD
Travoprost—Chest pain—Paclitaxel—lung cancer	0.000585	0.000658	CcSEcCtD
Travoprost—Hypotension—Cisplatin—lung cancer	0.000583	0.000656	CcSEcCtD
Travoprost—Anxiety—Paclitaxel—lung cancer	0.000583	0.000656	CcSEcCtD
Travoprost—Erythema—Docetaxel—lung cancer	0.000582	0.000655	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000581	0.000654	CcSEcCtD
Travoprost—Nausea—Topotecan—lung cancer	0.000578	0.000651	CcSEcCtD
Travoprost—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000578	0.000651	CcSEcCtD
Travoprost—Discomfort—Paclitaxel—lung cancer	0.000578	0.00065	CcSEcCtD
Travoprost—Fatigue—Gemcitabine—lung cancer	0.000577	0.00065	CcSEcCtD
Travoprost—Pain—Gemcitabine—lung cancer	0.000572	0.000644	CcSEcCtD
Travoprost—Constipation—Gemcitabine—lung cancer	0.000572	0.000644	CcSEcCtD
Travoprost—Nausea—Erlotinib—lung cancer	0.000572	0.000644	CcSEcCtD
Travoprost—Dry mouth—Paclitaxel—lung cancer	0.000572	0.000644	CcSEcCtD
Travoprost—Diarrhoea—Vinorelbine—lung cancer	0.00057	0.000642	CcSEcCtD
Travoprost—Dysgeusia—Docetaxel—lung cancer	0.00057	0.000642	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000568	0.00064	CcSEcCtD
Travoprost—Infection—Etoposide—lung cancer	0.000568	0.000639	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GIPR—lung cancer	0.000567	0.00888	CbGpPWpGaD
Travoprost—Feeling abnormal—Irinotecan—lung cancer	0.000566	0.000637	CcSEcCtD
Travoprost—Back pain—Docetaxel—lung cancer	0.000563	0.000634	CcSEcCtD
Travoprost—Dysuria—Methotrexate—lung cancer	0.000563	0.000634	CcSEcCtD
Travoprost—Gastrointestinal pain—Irinotecan—lung cancer	0.000562	0.000633	CcSEcCtD
Travoprost—Oedema—Paclitaxel—lung cancer	0.00056	0.000631	CcSEcCtD
Travoprost—Tachycardia—Etoposide—lung cancer	0.000558	0.000628	CcSEcCtD
Travoprost—Infection—Paclitaxel—lung cancer	0.000557	0.000627	CcSEcCtD
Travoprost—Dyspnoea—Cisplatin—lung cancer	0.000556	0.000626	CcSEcCtD
Travoprost—Skin disorder—Etoposide—lung cancer	0.000555	0.000625	CcSEcCtD
Travoprost—Feeling abnormal—Gemcitabine—lung cancer	0.000552	0.000621	CcSEcCtD
Travoprost—Dizziness—Vinorelbine—lung cancer	0.000551	0.00062	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—PTHLH—lung cancer	0.00055	0.00861	CbGpPWpGaD
Travoprost—Nervous system disorder—Paclitaxel—lung cancer	0.00055	0.000619	CcSEcCtD
Travoprost—Tachycardia—Paclitaxel—lung cancer	0.000547	0.000616	CcSEcCtD
Travoprost—Skin disorder—Paclitaxel—lung cancer	0.000544	0.000613	CcSEcCtD
Travoprost—Abdominal pain—Irinotecan—lung cancer	0.000543	0.000612	CcSEcCtD
Travoprost—Gastrointestinal disorder—Cisplatin—lung cancer	0.000539	0.000606	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—lung cancer	0.000537	0.000604	CcSEcCtD
Travoprost—Infestation—Methotrexate—lung cancer	0.000537	0.000604	CcSEcCtD
Travoprost—Depression—Methotrexate—lung cancer	0.000535	0.000603	CcSEcCtD
Travoprost—Hypotension—Etoposide—lung cancer	0.000534	0.000601	CcSEcCtD
Travoprost—Pain—Cisplatin—lung cancer	0.000533	0.000601	CcSEcCtD
Travoprost—Rash—Vinorelbine—lung cancer	0.000525	0.000591	CcSEcCtD
Travoprost—Dermatitis—Vinorelbine—lung cancer	0.000525	0.000591	CcSEcCtD
Travoprost—Hypotension—Paclitaxel—lung cancer	0.000524	0.00059	CcSEcCtD
Travoprost—Headache—Vinorelbine—lung cancer	0.000522	0.000588	CcSEcCtD
Travoprost—Conjunctivitis—Methotrexate—lung cancer	0.000522	0.000587	CcSEcCtD
Travoprost—Influenza—Doxorubicin—lung cancer	0.000521	0.000587	CcSEcCtD
Travoprost—Asthma—Doxorubicin—lung cancer	0.000521	0.000587	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ANXA1—lung cancer	0.000517	0.0081	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GIPR—lung cancer	0.000515	0.00807	CbGpPWpGaD
Travoprost—Palpitations—Docetaxel—lung cancer	0.000514	0.000579	CcSEcCtD
Travoprost—Feeling abnormal—Cisplatin—lung cancer	0.000514	0.000579	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000511	0.000575	CcSEcCtD
Travoprost—Dyspnoea—Etoposide—lung cancer	0.00051	0.000574	CcSEcCtD
Travoprost—Cough—Docetaxel—lung cancer	0.000508	0.000572	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—lung cancer	0.000508	0.000572	CcSEcCtD
Travoprost—Hypersensitivity—Irinotecan—lung cancer	0.000506	0.00057	CcSEcCtD
Travoprost—Hypertension—Docetaxel—lung cancer	0.000502	0.000566	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—lung cancer	0.000501	0.000564	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.0005	0.00784	CbGpPWpGaD
Travoprost—Dyspnoea—Paclitaxel—lung cancer	0.0005	0.000562	CcSEcCtD
Travoprost—Arthralgia—Docetaxel—lung cancer	0.000495	0.000558	CcSEcCtD
Travoprost—Chest pain—Docetaxel—lung cancer	0.000495	0.000558	CcSEcCtD
Travoprost—Myalgia—Docetaxel—lung cancer	0.000495	0.000558	CcSEcCtD
Travoprost—Nausea—Vinorelbine—lung cancer	0.000495	0.000557	CcSEcCtD
Travoprost—Gastrointestinal disorder—Etoposide—lung cancer	0.000493	0.000556	CcSEcCtD
Travoprost—Dyspepsia—Paclitaxel—lung cancer	0.000493	0.000555	CcSEcCtD
Travoprost—Asthenia—Irinotecan—lung cancer	0.000493	0.000555	CcSEcCtD
Travoprost—Fatigue—Etoposide—lung cancer	0.000493	0.000555	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000492	0.000554	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—APP—lung cancer	0.00049	0.00768	CbGpPWpGaD
Travoprost—Pain—Etoposide—lung cancer	0.000489	0.00055	CcSEcCtD
Travoprost—Constipation—Etoposide—lung cancer	0.000489	0.00055	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—lung cancer	0.000487	0.000549	CcSEcCtD
Travoprost—Dry mouth—Docetaxel—lung cancer	0.000485	0.000546	CcSEcCtD
Travoprost—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000484	0.000545	CcSEcCtD
Travoprost—Fatigue—Paclitaxel—lung cancer	0.000483	0.000544	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GRM8—lung cancer	0.000482	0.00755	CbGpPWpGaD
Travoprost—Asthenia—Gemcitabine—lung cancer	0.00048	0.000541	CcSEcCtD
Travoprost—Constipation—Paclitaxel—lung cancer	0.000479	0.000539	CcSEcCtD
Travoprost—Pain—Paclitaxel—lung cancer	0.000479	0.000539	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—lung cancer	0.000478	0.000538	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—lung cancer	0.000476	0.000536	CcSEcCtD
Travoprost—Oedema—Docetaxel—lung cancer	0.000475	0.000535	CcSEcCtD
Travoprost—Pruritus—Gemcitabine—lung cancer	0.000474	0.000533	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—lung cancer	0.000472	0.000532	CcSEcCtD
Travoprost—Infection—Docetaxel—lung cancer	0.000472	0.000531	CcSEcCtD
Travoprost—Feeling abnormal—Etoposide—lung cancer	0.000471	0.00053	CcSEcCtD
Travoprost—Diarrhoea—Irinotecan—lung cancer	0.00047	0.000529	CcSEcCtD
Travoprost—Gastrointestinal pain—Etoposide—lung cancer	0.000467	0.000526	CcSEcCtD
Travoprost—Nervous system disorder—Docetaxel—lung cancer	0.000466	0.000524	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—lung cancer	0.000465	0.000523	CcSEcCtD
Travoprost—Infestation—Doxorubicin—lung cancer	0.000465	0.000523	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—lung cancer	0.000464	0.000523	CcSEcCtD
Travoprost—Tachycardia—Docetaxel—lung cancer	0.000464	0.000522	CcSEcCtD
Travoprost—Feeling abnormal—Paclitaxel—lung cancer	0.000462	0.00052	CcSEcCtD
Travoprost—Skin disorder—Docetaxel—lung cancer	0.000461	0.000519	CcSEcCtD
Travoprost—Hypersensitivity—Cisplatin—lung cancer	0.00046	0.000517	CcSEcCtD
Travoprost—Gastrointestinal pain—Paclitaxel—lung cancer	0.000458	0.000516	CcSEcCtD
Travoprost—Diarrhoea—Gemcitabine—lung cancer	0.000458	0.000516	CcSEcCtD
Travoprost—Dizziness—Irinotecan—lung cancer	0.000454	0.000512	CcSEcCtD
Travoprost—Abdominal pain—Etoposide—lung cancer	0.000452	0.000509	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—lung cancer	0.000452	0.000509	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—lung cancer	0.000452	0.000509	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—lung cancer	0.00045	0.000507	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—lung cancer	0.000449	0.000506	CcSEcCtD
Travoprost—Asthenia—Cisplatin—lung cancer	0.000448	0.000504	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—lung cancer	0.000447	0.000503	CcSEcCtD
Travoprost—Hypotension—Docetaxel—lung cancer	0.000444	0.0005	CcSEcCtD
Travoprost—Abdominal pain—Paclitaxel—lung cancer	0.000443	0.000499	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000438	0.00686	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM8—lung cancer	0.000438	0.00686	CbGpPWpGaD
Travoprost—Angiopathy—Methotrexate—lung cancer	0.000437	0.000492	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—lung cancer	0.000436	0.000491	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—lung cancer	0.000435	0.00049	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—lung cancer	0.000434	0.000489	CcSEcCtD
Travoprost—Rash—Irinotecan—lung cancer	0.000433	0.000488	CcSEcCtD
Travoprost—Dermatitis—Irinotecan—lung cancer	0.000433	0.000487	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000433	0.000487	CcSEcCtD
Travoprost—Headache—Irinotecan—lung cancer	0.00043	0.000485	CcSEcCtD
Travoprost—Diarrhoea—Cisplatin—lung cancer	0.000427	0.000481	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—lung cancer	0.000425	0.000478	CcSEcCtD
Travoprost—Dyspnoea—Docetaxel—lung cancer	0.000423	0.000477	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—lung cancer	0.000422	0.000475	CcSEcCtD
Travoprost—Rash—Gemcitabine—lung cancer	0.000422	0.000475	CcSEcCtD
Travoprost—Dermatitis—Gemcitabine—lung cancer	0.000422	0.000475	CcSEcCtD
Travoprost—Hypersensitivity—Etoposide—lung cancer	0.000421	0.000474	CcSEcCtD
Travoprost—Erythema—Methotrexate—lung cancer	0.000419	0.000472	CcSEcCtD
Travoprost—Headache—Gemcitabine—lung cancer	0.000419	0.000472	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—lung cancer	0.000418	0.000471	CcSEcCtD
Travoprost—Dyspepsia—Docetaxel—lung cancer	0.000418	0.000471	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.000417	0.00654	CbGpPWpGaD
Travoprost—Pharyngitis—Doxorubicin—lung cancer	0.000414	0.000466	CcSEcCtD
Travoprost—Hypersensitivity—Paclitaxel—lung cancer	0.000413	0.000465	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—lung cancer	0.000412	0.000464	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—lung cancer	0.000411	0.000462	CcSEcCtD
Travoprost—Gastrointestinal disorder—Docetaxel—lung cancer	0.00041	0.000462	CcSEcCtD
Travoprost—Asthenia—Etoposide—lung cancer	0.00041	0.000462	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—lung cancer	0.00041	0.000462	CcSEcCtD
Travoprost—Fatigue—Docetaxel—lung cancer	0.000409	0.000461	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—lung cancer	0.000409	0.00046	CcSEcCtD
Travoprost—Nausea—Irinotecan—lung cancer	0.000408	0.000459	CcSEcCtD
Travoprost—Pain—Docetaxel—lung cancer	0.000406	0.000457	CcSEcCtD
Travoprost—Constipation—Docetaxel—lung cancer	0.000406	0.000457	CcSEcCtD
Travoprost—Back pain—Methotrexate—lung cancer	0.000406	0.000457	CcSEcCtD
Travoprost—Pruritus—Etoposide—lung cancer	0.000404	0.000455	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—lung cancer	0.000402	0.000453	CcSEcCtD
Travoprost—Asthenia—Paclitaxel—lung cancer	0.000402	0.000453	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AXL—lung cancer	0.000401	0.00629	CbGpPWpGaD
Travoprost—Nausea—Gemcitabine—lung cancer	0.000398	0.000448	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—OXTR—lung cancer	0.000397	0.00622	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRP—lung cancer	0.000397	0.00622	CbGpPWpGaD
Travoprost—Pruritus—Paclitaxel—lung cancer	0.000396	0.000446	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—lung cancer	0.000395	0.000445	CcSEcCtD
Travoprost—Rash—Cisplatin—lung cancer	0.000393	0.000443	CcSEcCtD
Travoprost—Dermatitis—Cisplatin—lung cancer	0.000393	0.000442	CcSEcCtD
Travoprost—Feeling abnormal—Docetaxel—lung cancer	0.000391	0.000441	CcSEcCtD
Travoprost—Diarrhoea—Etoposide—lung cancer	0.000391	0.00044	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—lung cancer	0.00039	0.000439	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—lung cancer	0.000389	0.000438	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—lung cancer	0.000389	0.000438	CcSEcCtD
Travoprost—Gastrointestinal pain—Docetaxel—lung cancer	0.000388	0.000437	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—lung cancer	0.000387	0.000436	CcSEcCtD
Travoprost—Diarrhoea—Paclitaxel—lung cancer	0.000383	0.000432	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—AVP—lung cancer	0.000381	0.00597	CbGpPWpGaD
Travoprost—Angiopathy—Doxorubicin—lung cancer	0.000379	0.000426	CcSEcCtD
Travoprost—Malaise—Methotrexate—lung cancer	0.000378	0.000426	CcSEcCtD
Travoprost—Dizziness—Etoposide—lung cancer	0.000378	0.000425	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—lung cancer	0.000377	0.000424	CcSEcCtD
Travoprost—Vertigo—Methotrexate—lung cancer	0.000377	0.000424	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—lung cancer	0.000376	0.000423	CcSEcCtD
Travoprost—Abdominal pain—Docetaxel—lung cancer	0.000375	0.000423	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GNG11—lung cancer	0.000372	0.00582	CbGpPWpGaD
Travoprost—Dizziness—Paclitaxel—lung cancer	0.000371	0.000417	CcSEcCtD
Travoprost—Nausea—Cisplatin—lung cancer	0.000371	0.000417	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.00037	0.0058	CbGpPWpGaD
Travoprost—Cough—Methotrexate—lung cancer	0.000366	0.000412	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—lung cancer	0.000366	0.000412	CcSEcCtD
Travoprost—Erythema—Doxorubicin—lung cancer	0.000363	0.000409	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—OXTR—lung cancer	0.00036	0.00565	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRP—lung cancer	0.00036	0.00565	CbGpPWpGaD
Travoprost—Rash—Etoposide—lung cancer	0.00036	0.000406	CcSEcCtD
Travoprost—Dermatitis—Etoposide—lung cancer	0.00036	0.000405	CcSEcCtD
Travoprost—Headache—Etoposide—lung cancer	0.000358	0.000403	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—lung cancer	0.000357	0.000402	CcSEcCtD
Travoprost—Myalgia—Methotrexate—lung cancer	0.000357	0.000402	CcSEcCtD
Travoprost—Chest pain—Methotrexate—lung cancer	0.000357	0.000402	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—lung cancer	0.000356	0.0004	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000355	0.000399	CcSEcCtD
Travoprost—Rash—Paclitaxel—lung cancer	0.000353	0.000398	CcSEcCtD
Travoprost—Dermatitis—Paclitaxel—lung cancer	0.000353	0.000397	CcSEcCtD
Travoprost—Discomfort—Methotrexate—lung cancer	0.000353	0.000397	CcSEcCtD
Travoprost—Back pain—Doxorubicin—lung cancer	0.000351	0.000396	CcSEcCtD
Travoprost—Headache—Paclitaxel—lung cancer	0.000351	0.000395	CcSEcCtD
Travoprost—Hypersensitivity—Docetaxel—lung cancer	0.00035	0.000394	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—lung cancer	0.000342	0.000385	CcSEcCtD
Travoprost—Asthenia—Docetaxel—lung cancer	0.000341	0.000384	CcSEcCtD
Travoprost—Infection—Methotrexate—lung cancer	0.00034	0.000383	CcSEcCtD
Travoprost—Nausea—Etoposide—lung cancer	0.000339	0.000382	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GNG11—lung cancer	0.000337	0.00529	CbGpPWpGaD
Travoprost—Ill-defined disorder—Doxorubicin—lung cancer	0.000337	0.000379	CcSEcCtD
Travoprost—Pruritus—Docetaxel—lung cancer	0.000336	0.000378	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—lung cancer	0.000336	0.000378	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ADCY1—lung cancer	0.000334	0.00524	CbGpPWpGaD
Travoprost—Nausea—Paclitaxel—lung cancer	0.000333	0.000375	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—lung cancer	0.000333	0.000374	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000332	0.00521	CbGpPWpGaD
Travoprost—Malaise—Doxorubicin—lung cancer	0.000328	0.000369	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—lung cancer	0.000326	0.000367	CcSEcCtD
Travoprost—Diarrhoea—Docetaxel—lung cancer	0.000325	0.000366	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—lung cancer	0.000321	0.000361	CcSEcCtD
Travoprost—Hypotension—Methotrexate—lung cancer	0.00032	0.00036	CcSEcCtD
Travoprost—Cough—Doxorubicin—lung cancer	0.000317	0.000357	CcSEcCtD
Travoprost—Dizziness—Docetaxel—lung cancer	0.000314	0.000354	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—lung cancer	0.000314	0.000353	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—COL4A2—lung cancer	0.000312	0.00489	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000312	0.000351	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PTHLH—lung cancer	0.000311	0.00487	CbGpPWpGaD
Travoprost—Chest pain—Doxorubicin—lung cancer	0.000309	0.000348	CcSEcCtD
Travoprost—Myalgia—Doxorubicin—lung cancer	0.000309	0.000348	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—lung cancer	0.000309	0.000348	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—lung cancer	0.000308	0.000347	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000307	0.000346	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—lung cancer	0.000306	0.000344	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—lung cancer	0.000305	0.000344	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GIPR—lung cancer	0.000304	0.00477	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADCY1—lung cancer	0.000303	0.00475	CbGpPWpGaD
Travoprost—Dry mouth—Doxorubicin—lung cancer	0.000302	0.00034	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—lung cancer	0.000301	0.000339	CcSEcCtD
Travoprost—Rash—Docetaxel—lung cancer	0.000299	0.000337	CcSEcCtD
Travoprost—Dermatitis—Docetaxel—lung cancer	0.000299	0.000337	CcSEcCtD
Travoprost—Headache—Docetaxel—lung cancer	0.000298	0.000335	CcSEcCtD
Travoprost—Oedema—Doxorubicin—lung cancer	0.000296	0.000334	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PPP2R1B—lung cancer	0.000296	0.00463	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Methotrexate—lung cancer	0.000296	0.000333	CcSEcCtD
Travoprost—Fatigue—Methotrexate—lung cancer	0.000295	0.000332	CcSEcCtD
Travoprost—Infection—Doxorubicin—lung cancer	0.000294	0.000332	CcSEcCtD
Travoprost—Pain—Methotrexate—lung cancer	0.000293	0.00033	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ANXA1—lung cancer	0.000292	0.00458	CbGpPWpGaD
Travoprost—Nervous system disorder—Doxorubicin—lung cancer	0.000291	0.000327	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—lung cancer	0.000289	0.000326	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—lung cancer	0.000288	0.000324	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SDC4—lung cancer	0.000284	0.00445	CbGpPWpGaD
Travoprost—Nausea—Docetaxel—lung cancer	0.000282	0.000318	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—lung cancer	0.000282	0.000318	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PTHLH—lung cancer	0.000282	0.00442	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Methotrexate—lung cancer	0.00028	0.000315	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000279	0.00437	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DUSP3—lung cancer	0.000278	0.00436	CbGpPWpGaD
Travoprost—Hypotension—Doxorubicin—lung cancer	0.000277	0.000312	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—APP—lung cancer	0.000277	0.00434	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RHEB—lung cancer	0.000273	0.00427	CbGpPWpGaD
Travoprost—Abdominal pain—Methotrexate—lung cancer	0.000271	0.000305	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00027	0.000304	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000267	0.00418	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ANXA1—lung cancer	0.000265	0.00416	CbGpPWpGaD
Travoprost—Dyspnoea—Doxorubicin—lung cancer	0.000264	0.000298	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—lung cancer	0.000261	0.000294	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GRM8—lung cancer	0.000259	0.00405	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000257	0.00403	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000256	0.000288	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—lung cancer	0.000256	0.000288	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000254	0.00398	CbGpPWpGaD
Travoprost—Pain—Doxorubicin—lung cancer	0.000253	0.000285	CcSEcCtD
Travoprost—Constipation—Doxorubicin—lung cancer	0.000253	0.000285	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—POMC—lung cancer	0.000253	0.00397	CbGpPWpGaD
Travoprost—Hypersensitivity—Methotrexate—lung cancer	0.000252	0.000284	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—APP—lung cancer	0.000251	0.00394	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SKI—lung cancer	0.00025	0.00392	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—lung cancer	0.000246	0.00386	CbGpPWpGaD
Travoprost—Asthenia—Methotrexate—lung cancer	0.000246	0.000277	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—lung cancer	0.000244	0.000275	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—lung cancer	0.000242	0.000273	CcSEcCtD
Travoprost—Pruritus—Methotrexate—lung cancer	0.000242	0.000273	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.00024	0.00376	CbGpPWpGaD
Travoprost—Abdominal pain—Doxorubicin—lung cancer	0.000234	0.000264	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—lung cancer	0.000234	0.000264	CcSEcCtD
Travoprost—Dizziness—Methotrexate—lung cancer	0.000226	0.000255	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.00022	0.00345	CbGpPWpGaD
Travoprost—Hypersensitivity—Doxorubicin—lung cancer	0.000218	0.000246	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PXN—lung cancer	0.000217	0.00341	CbGpPWpGaD
Travoprost—Rash—Methotrexate—lung cancer	0.000216	0.000243	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—lung cancer	0.000216	0.000243	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AVP—lung cancer	0.000215	0.00337	CbGpPWpGaD
Travoprost—Headache—Methotrexate—lung cancer	0.000214	0.000241	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AKR1C1—lung cancer	0.000213	0.00334	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—OXTR—lung cancer	0.000213	0.00334	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRP—lung cancer	0.000213	0.00334	CbGpPWpGaD
Travoprost—Asthenia—Doxorubicin—lung cancer	0.000213	0.000239	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—lung cancer	0.00021	0.000236	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000204	0.00319	CbGpPWpGaD
Travoprost—Nausea—Methotrexate—lung cancer	0.000203	0.000229	CcSEcCtD
Travoprost—Diarrhoea—Doxorubicin—lung cancer	0.000203	0.000228	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GNG11—lung cancer	0.000199	0.00312	CbGpPWpGaD
Travoprost—Dizziness—Doxorubicin—lung cancer	0.000196	0.000221	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CXCL8—lung cancer	0.000196	0.00307	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AVP—lung cancer	0.000196	0.00306	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000195	0.00306	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFC—lung cancer	0.00019	0.00297	CbGpPWpGaD
Travoprost—Rash—Doxorubicin—lung cancer	0.000187	0.00021	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—lung cancer	0.000187	0.00021	CcSEcCtD
Travoprost—Headache—Doxorubicin—lung cancer	0.000186	0.000209	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ADCY1—lung cancer	0.000179	0.00281	CbGpPWpGaD
Travoprost—Nausea—Doxorubicin—lung cancer	0.000176	0.000198	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PPP2R1B—lung cancer	0.000175	0.00274	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SMARCA4—lung cancer	0.000175	0.00274	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HSPB1—lung cancer	0.000169	0.00264	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTHLH—lung cancer	0.000167	0.00261	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ANXA1—lung cancer	0.000157	0.00245	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FLT1—lung cancer	0.000152	0.00238	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CG—lung cancer	0.00015	0.00236	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOTCH3—lung cancer	0.000149	0.00233	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APP—lung cancer	0.000149	0.00233	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGF9—lung cancer	0.000147	0.00231	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—POMC—lung cancer	0.000143	0.00224	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUNB—lung cancer	0.000141	0.0022	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CG—lung cancer	0.000136	0.00214	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CD—lung cancer	0.000132	0.00207	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—POMC—lung cancer	0.00013	0.00204	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STK11—lung cancer	0.000128	0.002	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6R—lung cancer	0.000127	0.00199	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FOXO3—lung cancer	0.000123	0.00193	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAP2K1—lung cancer	0.000121	0.00189	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CD—lung cancer	0.00012	0.00188	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AVP—lung cancer	0.000115	0.00181	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CB—lung cancer	0.000115	0.0018	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1R—lung cancer	0.000111	0.00174	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL8—lung cancer	0.000111	0.00173	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HES1—lung cancer	0.000109	0.00171	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—RAF1—lung cancer	0.000107	0.00168	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—IL2—lung cancer	0.000106	0.00166	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CB—lung cancer	0.000105	0.00164	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL8—lung cancer	0.000101	0.00157	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ERBB3—lung cancer	9.98e-05	0.00156	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL2—lung cancer	9.6e-05	0.00151	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TERT—lung cancer	9.57e-05	0.0015	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGFR1—lung cancer	9.29e-05	0.00146	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HIF1A—lung cancer	9.15e-05	0.00143	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA1—lung cancer	8.83e-05	0.00138	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KDR—lung cancer	8.75e-05	0.00137	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APC—lung cancer	8.06e-05	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CG—lung cancer	8.06e-05	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KIT—lung cancer	8.06e-05	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NRAS—lung cancer	8.06e-05	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGF—lung cancer	7.97e-05	0.00125	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK3—lung cancer	7.72e-05	0.00121	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—lung cancer	7.67e-05	0.0012	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BRAF—lung cancer	7.58e-05	0.00119	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6R—lung cancer	7.49e-05	0.00117	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CREBBP—lung cancer	7.48e-05	0.00117	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EGFR—lung cancer	7.35e-05	0.00115	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAP2K1—lung cancer	7.13e-05	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CD—lung cancer	7.09e-05	0.00111	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—lung cancer	7.02e-05	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KRAS—lung cancer	6.94e-05	0.00109	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—lung cancer	6.38e-05	0.000999	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MDM2—lung cancer	6.35e-05	0.000995	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RAF1—lung cancer	6.33e-05	0.000992	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ERBB2—lung cancer	6.26e-05	0.000981	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTOR—lung cancer	6.18e-05	0.000968	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CB—lung cancer	6.18e-05	0.000968	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL8—lung cancer	5.94e-05	0.00093	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HRAS—lung cancer	5.9e-05	0.000924	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—lung cancer	5.74e-05	0.000899	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP3—lung cancer	5.68e-05	0.00089	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL2—lung cancer	5.67e-05	0.000889	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—lung cancer	5.65e-05	0.000885	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCND1—lung cancer	5.53e-05	0.000867	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUN—lung cancer	5.52e-05	0.000865	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—lung cancer	5.37e-05	0.000841	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN1A—lung cancer	5.35e-05	0.000838	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTEN—lung cancer	5.34e-05	0.000837	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—lung cancer	5.21e-05	0.000816	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EP300—lung cancer	5.09e-05	0.000798	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SRC—lung cancer	4.95e-05	0.000776	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—lung cancer	4.82e-05	0.000756	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT3—lung cancer	4.77e-05	0.000748	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NRAS—lung cancer	4.76e-05	0.000746	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK3—lung cancer	4.56e-05	0.000715	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—lung cancer	4.44e-05	0.000695	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGFR—lung cancer	4.34e-05	0.00068	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KRAS—lung cancer	4.1e-05	0.000642	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—lung cancer	3.77e-05	0.00059	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TP53—lung cancer	3.64e-05	0.000571	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRAS—lung cancer	3.48e-05	0.000546	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—lung cancer	3.33e-05	0.000523	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—lung cancer	3.08e-05	0.000482	CbGpPWpGaD
